Trials / Recruiting
RecruitingNCT05699213
MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening
A Pilot Study Evaluating the Feasibility of Novel MRI Sequences and Blood-Based Biomarkers for Discriminating Nodules Found During Lung Cancer Screening
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Cedars-Sinai Medical Center · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this pilot observational study is to evaluate the accrual and retention rate of a study population from a centralized lung cancer screening program to support MRI and blood-based biomarker research for lung cancer screening.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Lung MRI | MRI of the lung |
| DIAGNOSTIC_TEST | Blood Draw | Blood Draw |
Timeline
- Start date
- 2023-06-27
- Primary completion
- 2026-06-27
- Completion
- 2026-08-27
- First posted
- 2023-01-26
- Last updated
- 2023-08-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05699213. Inclusion in this directory is not an endorsement.